For most injectable GLP-1 receptor agonists (such as semaglutide injections, dulaglutide, and liraglutide), food has minimal impact on drug absorption because the medication is delivered directly into subcutaneous tissue and absorbed into the systemic circulation independently of the gastrointestinal tract
doi:10.1016/j.physbeh.2008.07.018 231
In addition, GLP-1, but not GIP, inhibits glucagon secretion, and together these actions form the basis for the use of GLP-1 receptor agonists (GLP-1RAs) in T2DM therapy [6]
Some of the ingredients might increase the bodys natural GLP-1 hormone, but so does food in general when people eat, Jay says
Semaglutide (Ozempic, Wegovy) works entirely through this single receptor
The project is supported by the Italian PNRR-MAD project (PNRR-MAD-2022-12375656)